## Abstract We assessed the status of dopamine nerve terminals in patients treated with dopamine receptor blocking agents (DRBAs) who had developed drugβinduced parkinsonism (DIP). We performed [^123^I]FPβCIT SPET in 32 consecutive patients who were on DRBAs for at least 6 months and developed extr
β¦ LIBER β¦
Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism
β Scribed by Michele Tinazzi; Angelo Antonini; Tommaso Bovi; Isabella Pasquin; Maria Steinmayr; Giuseppe Moretto; Antonio Fiaschi; Sarah Ottaviani
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 180 KB
- Volume
- 256
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
[123I]FP-CIT SPET imaging in drug-induce
β
Michele Tinazzi; Sarah Ottaviani; Ioannis U. Isaias; Isabella Pasquin; Maria Ste
π
Article
π
2008
π
John Wiley and Sons
π
English
β 88 KB
Clinical features and123I-FP-CIT SPECT i
β
Francisco J. Diaz-Corrales; Salome Sanz-Viedma; David Garcia-Solis; Teresa Escob
π
Article
π
2009
π
Springer
π
English
β 185 KB
The cost effectiveness of123I-FP-CIT SPE
β
Koen Van Laere; Ludwig Everaert; Lieven Annemans; Michel Gonce; Wim Vandenberghe
π
Article
π
2008
π
Springer
π
English
β 392 KB
Effect of age and gender on dopamine tra
β
Jules Lavalaye; Jan Booij; Liesbeth Reneman; Jan B. A. Habraken; Eric A. van Roy
π
Article
π
2000
π
Springer
π
English
β 23 KB
Clinical correlation of the binding pote
β
Valentina Berti; Alberto Pupi; Silvia Ramat; Eleonora Vanzi; Maria Teresa De Cri
π
Article
π
2008
π
Springer
π
English
β 315 KB
123I-IBZM binding compared with long-ter
β
Dr. Johannes Schwarz; Klaus Tatsch; Thomas Gasser; Guy Arnold; Oliver Pogarell;
π
Article
π
1998
π
John Wiley and Sons
π
English
β 361 KB
We performed a prospective clinical follow up (mean follow up, 36 months; range, 24-56 months) of 65 patients with de novo parkinsonism in whom imaging of dopamine D2 receptors was performed before the initiation of dopaminomimetic therapy by means of 123I-iodobenzamide-single-photon-emission comput